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Abstract
Background: Patient decision aids aim to present evidence relevant to a health decision in understandable ways to
support patients through the process of making evidence-informed, values-congruent health decisions. It is
recommended that, when developing these tools, teams involve people who may ultimately use them. However,
there is little empirical evidence about how best to undertake this involvement, particularly for specific populations
of users such as vulnerable populations.
Methods: To describe and compare the development practices of research teams that did and did not specifically
involve members of vulnerable populations in the development of patient decision aids, we conducted a
secondary analysis of data from a systematic review about the development processes of patient decision aids.
Then, to further explain our quantitative results, we conducted semi-structured telephone interviews with 10 teams:
6 that had specifically involved members of vulnerable populations and 4 that had not. Two independent analysts
thematically coded transcribed interviews.
Results: Out of a total of 187 decision aid development projects, 30 (16%) specifically involved members of
vulnerable populations. The specific involvement of members of vulnerable populations in the development
process was associated with conducting informal needs assessment activities (73% vs. 40%, OR 2.96, 95% CI 1.18–7.99,
P = .02) and recruiting participants through community-based organizations (40% vs. 11%, OR 3.48, 95% CI 1.23–9.83,
P = .02). In interviews, all developers highlighted the importance, value and challenges of involving potential
users. Interviews with developers whose projects had involved members of vulnerable populations suggested
that informal needs assessment activities served to center the decision aid around users’ needs, to better avoid stigma,
and to ensure that the topic truly matters to the community. Partnering with community-based organizations may
facilitate relationships of trust and may also provide a non-threatening and accessible location for research activities.
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Conclusions: There are a small number of key differences in the development processes for patient decision aids in
which members of vulnerable populations were or were not specifically involved. Some of these practices may require
additional time or resources. To address health inequities, researchers, communities and funders may need to increase
awareness of these approaches and plan accordingly.
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Background
Patient decision aids are a core tool of shared decision
making. These tools, often in the form of booklets, web-
sites, videos, or a combination of media, are intended to
help people make health decisions by providing informa-
tion about the potential benefits and harms of their
options, along with support for determining how well or
poorly each option aligns with what matters to the per-
son or people most affected by the decision. As evi-
denced in a meta-analysis of 115 trials, these tools
increase the likelihood of people making evidence-
informed, values-congruent health decisions [1]. The
International Patient Decision Aids Standards stipulate
that patient decision aids should be developed with user
involvement [2, 3], meaning patients, caregivers, families,
surrogate decision makers and health care professionals,
as appropriate. Involving users in the development of pa-
tient decision aids is recommended because, in principle,
such involvement should help patient decision aids better
meet the needs of the people for whom they are intended,
rendering the tools more acceptable, comprehensible, use-
ful, and usable. However, despite the general recommen-
dation in favor of involving people in the development of
patient decision aids that they or others like them may
use, there is little guidance and scant evidence regarding
optimal practices for such involvement.
The question of how best to involve people in the de-
velopment of a patient decision aid may be particularly
important when those people are members of vulnerable
populations. A meta-analysis demonstrated that shared
decision-making interventions, including but not limited
to patient decision aids, may be more beneficial to some
vulnerable populations, specifically, those with lower
socioeconomic status and literacy [4]. Other work has
similarly highlighted the potential of patient decision
support tools for members of vulnerable populations
[5, 6]. From a public health perspective, patient decision
aids may therefore contribute to the overall objective of
reducing health inequities. However, to achieve this
objective, patient decision aids must be usable by mem-
bers of vulnerable populations who already experience
additional difficulties when engaging in shared decision
making [7]. Furthermore, members of vulnerable popula-
tions are still under-represented in health research overall
[8], and may also be less represented in the development
of patient decision aids, resulting in tools that may be dif-
ficult for them to use [9]. Ensuring that members of vul-
nerable populations can participate in shared decision
making is essential to avoid perpetuating—or worse,
exacerbating—health inequities [10, 11]. Developing
patient decision aids that work for members of vulnerable
populations is part of this effort.
According to Flaskerud and Winslow’s conceptual
framework, vulnerable populations are defined as social
groups with a higher risk of health problems [12]. These
groups include people who are poor, discriminated
against, stigmatized, marginalized or disenfranchised [12].
People who are members of vulnerable populations may
be disadvantaged, for example, due to psychological or
cognitive characteristics (e.g., mental illness, low literacy),
socio-economic or cultural characteristics (e.g., education,
income, race, language) or may experience discrimination
or stigma for other reasons (e.g., alcohol or drug depend-
encies, sexual orientation) [12, 13].
A systematic review on strategies for improving health
and medical research involving socially disadvantaged
groups [8] showed that to better represent members of
vulnerable populations, research teams may have to an-
ticipate higher budgets, longer timeframes and the need
to establish partnerships with communities. However, it
is unknown to what extent these findings apply to the
development of tools such as patient decision aids.
To improve the knowledge and health care decision
making of vulnerable populations, it is important to cre-
ate patient decision aids that are meaningful, under-
standable, and usable for the people who will use them.
Our study therefore aimed to describe how members of
vulnerable populations have been specifically involved in
the development of patient decision aids, and to investi-
gate which, if any, development steps might be similar
or different between development processes that did and




Our study used a mixed methods design [14, 15] struc-
tured in two phases. In phase 1, we conducted a secondary
analysis of a systematic review about how different teams
have developed patient decision aids to quantitatively
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compare practices of teams that did and did not explicitly
involve members of vulnerable populations. In phase 2,
we conducted semi-structured interviews with 10 decision
aid developers: 6 who involved members of vulnerable
populations and 4 who did not. These interviews were de-
signed to help us explore concepts identified in phase 1 in
greater depth, along with other themes that were not pos-
sible to extract from published reports. Our study was ap-
proved by the Research Ethics Committee of Laval
University (approval number 2014-035/26-05-2015).
Phase 1
Data collection
Our systematic review methods are described in full else-
where [16]. Briefly, we included articles that described at
least one step of the development of a patient decision
aid, with no other inclusion or exclusion criteria. Two in-
dependent analysts extracted data about development pro-
cesses based on a conceptual framework of user-centered
design [16]. We reconciled disagreements at regular meet-
ings and contacted authors by email to validate extracted
data. For this study, we used only data that we were able
to validate with the original authors.
In order to achieve the aims of this study, we identified
development processes specifically involving members of
vulnerable populations. First, we developed a preliminary
set of criteria to identify these projects when extracting
data. The criteria were based on Flaskerud and
Winslow’s framework [12] and the Centers for Disease
Control and Prevention’s public health workbook on
reaching at-risk populations in an emergency [13]. Two
independent reviewers (MD, MET, both Master’s stu-
dents in community health with backgrounds in soci-
ology) then re-reviewed all extracted data along with the
original article or articles for each project. These
reviewers independently classified each development
process into one of two groups: projects that specifically
included members of vulnerable populations and pro-
jects that did not. These reviewers also classified the
type of vulnerability into one or more of eight categories
based the frameworks noted above: (a) race and ethni-
city, (b) lower socioeconomic status (lower education or
lower income), (c) lower literacy, (d) mental health prob-
lems, (e) physical disabilities, (f ) older adults (65+), (g)
children and adolescents (18-), (h) other. The reviewers
met regularly to discuss and resolve any disagreements.
To validate data extracted from published articles, we
contacted authors of papers included in our systematic
review by email and asked them to verify the extracted
data or to provide clarification, corrections or additional
information as necessary. As part of this process, we
specifically asked about the involvement of members of
vulnerable populations during the development of their
patient decision aid.
Analyses
To determine whether any differences exist in develop-
ment practices between teams that did and did not in-
volve members of vulnerable populations, we conducted
quantitative analyses to explore which, if any, variables
relevant to the development of a patient decision aid are
significantly associated with the involvement of members
of vulnerable populations. Our dependent variable was
therefore whether or not the project specifically involved
members of vulnerable populations. We identified 31
potential independent variables in our data matrix that
were of primary interest to us due to their importance
within our conceptual frameworks of user-centered de-
sign and vulnerability, and had acceptable distribution
properties within the secondary data set. We present the
full list of these variables along with summary statistics
in Additional file 1: Appendix 3. We used bivariate ana-
lyses with a threshold of P > .20 to rule out any variables
that were unlikely to be associated with our dependent
variable and entered all remaining variables into a multi-
variable logistic regression.
To inform sampling plans in phase 2, for all independ-
ent variables in our regression, we also determined
whether any differences existed between two groups of
categories of vulnerability using Fisher Exact tests. The
first group included the categories race and ethnicity,
lower socioeconomic status, lower literacy, and mental
health problems. The second group included physical
disabilities, older adults, children and adolescents, and
other categories of potential vulnerability. We performed
all analyses in R, version 3.2.1 [17].
Phase 2
Data collection
In order to explore the involvement of members of vul-
nerable populations in more depth, in phase 2 we con-
ducted semi-structured telephone interviews with
developers of patient decision aids. We elected to inter-
view developers as these are the people who planned
and conducted the development processes.
Recognizing that there are many ways in which vulner-
ability may present and to remain within the scope of
our project, we elected to focus on the social and eco-
nomic dimensions of vulnerability (race and ethnicity,
lower socioeconomic status, lower literacy, mental health
problems). We identified authors who had developed pa-
tient decision aids (hereafter referred to as developers)
from the projects included in the systematic review in
phase 1 using maximum variation sampling [18]. Specif-
ically, we aimed to maximize diversity with respect to
the types of vulnerable populations involved within our
subgroup and the development methods used. To select
projects from which we wished to interview developers,
during data extraction, analysts (MD, MET, TP, GV, EB)
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indicated, according to their subjective assessment, any
article that they believed described an especially high
quality development process. We then pooled all articles
that had been thus flagged. Two other team members
(SCD, HW) independently screened these articles and
came to consensus on which project teams might best
be able to provide the widest range of insights, consult-
ing with the lead author (MD) in cases of questions re-
garding vulnerability. When selecting projects for
interviews, in addition to seeking maximum variation,
we prioritized projects with more recently published ar-
ticles to facilitate recall and to better capture current
methods.
We contacted the corresponding authors of articles
associated with each of these projects to invite them to
participate in a 60-min telephone interview conducted
by members of the research team (SCD for all inter-
views, MD for interviews with teams identified as having
involved members of vulnerable populations). We of-
fered authors an honorarium of CAD$100 in appreci-
ation of their time. We aimed to interview ten teams
approximately balanced between those that did and
those that did not specifically involve members of vul-
nerable populations.
The interviews focused on six main themes: (1) De-
scription of the development process, (2) Goals of the
development process, (3) Role of patients in the project,
(4) Nature and level of patient participation in the
development process, (5) Barriers and facilitators to in-
volving members of vulnerable populations, (6) Lessons
learned. Additional file 1: Appendix 1 shows the inter-
view guide. To glean insights from developers regarding
differences in development practices that we identified
in phase 1, we specifically asked developers who had in-
volved members of vulnerable populations, “Your study
was identified as one of the studies that included users
who may be from socially or economically disadvantaged
populations. In our quantitative analyses we found the
following differences between studies that did and did
not involve people from such populations: [describe dif-
ferences]. I’m wondering if you can comment on those
differences? To what extent do these findings reflect or
fail to reflect your own experiences in this project?”
In addition to developers, we originally planned to also
interview patients who had been involved in the devel-
opment processes. However, numerous obstacles that we
were unable to resolve (e.g., Institutional Review Board
regulations, losses of contact information, principal
investigators having changed institutions) prevented us
from doing so.
Analyses
We transcribed interviews verbatim and two independ-
ent researchers (MD, MET) analyzed them qualitatively
in NVivo 10, following standard steps of deductive the-
matic analysis [19]. The lead author (MD) generated a
Table 1 Associations between development process variables and involvement of members of vulnerable populations
Variable Projects that specifically involved
members of vulnerable populations
(n = 30)
Projects that did not specifically
involve members of vulnerable




Decision aid users were involved in an
informal needs assessment
22 (73%) 63 (40%) 2.96 (1.18,7.99), P = .02*
Decision aid users were involved in a content
review prior to prototype development
9 (30%) 25 (16%) 0.96 (0.31,2.71), P = .94
Decision aid users were involved in a
pilot test
26 (87%) 111 (71%) 1.75 (0.53,7.03), P = .37
Developers asked users their thoughts
& opinions of the tool
27 (90%) 117 (75%) 1.67 (0.48,7.83), P = .44
Developers assessed the impact of the
decision aid on users
25 (83%) 146 (93%) 0.49 (0.12,2.10), P = .32
An advisory panel of users was involved
in the project
8 (27%) 16 (10%) 2.04 (0.61,6.47), P = .24
Decision aid users were recruited through
community-based organizations
12 (40%) 17 (11%) 3.48 (1.23,9.83), P = .02*
Decision aid users were compensated/
incentivized in some way
16 (53%) 54 (34%) 1.41 (0.55,3.54), P = .47
An expert panel of academics, clinicians,
etc. was involved in the project
22 (73%) 90 (57%) 1.76 (0.66,5.10), P = .27
The project team had formal links with
a specific patient or consumer organization
7 (23%) 21 (13%) 0.87 (0.23,2.92), P = .83
*P < .05
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set of initial themes. Then, the lead and second author
(MET) refined and sought themes in an iterative manner
until we reached consensus and identified no new
themes. We then reviewed, defined and named themes
with two other authors (SCD, HW).
Results
Phase 1
Full results of the larger systematic review will be
described in a companion paper (G. Vaisson, personal
communication [20]). Briefly, we identified 443 publica-
tions about the development of a patient decision aid.
After consolidating multiple articles from the same pro-
jects, our final data set consisted of 283 patient decision
aid development projects. We were able to obtain con-
firmation or correction of our extracted data from 187
out of 283 teams, for a total response rate of 66%.
Within the 187 projects, 30 (16%) specifically involved
members of vulnerable populations in the development
process. The full list of projects and articles is available
in Additional file 1: Appendix 2.
Our multivariate logistic regression identified 2 out of
10 variables that were significantly associated with
whether or not patient decision aid development
processes specifically involved members of vulnerable
populations. Conducting informal needs assessments
and working with community-based organizations were
associated with the specific involvement of members of
vulnerable populations. Table 1 shows frequencies and
regression results. (See Additional file 1: Appendix 3 for
full details of all non-retained variables.)
There were no significant differences between the cat-
egories of vulnerability in these 10 variables. This lack of
difference supported our sampling plans for phase 2.
Phase 2
We identified 14 projects for potential interviews. Out
of these, 1 developer team did not respond to our
request and 3 declined to participate due to time restric-
tions or other precluding conditions, including project
leaders being away on leave. Thus, we interviewed ten
developer teams in total (71% of those invited): 6 that
had specifically involved people from populations that
may be vulnerable due to race and ethnicity, lower so-
cioeconomic status, lower literacy, or mental health con-
ditions (projects numbered 1 to 6 in quotes), and 4 that
did not (projects 7 to 10 in quotes) for comparison. One
project had two team members participate; for all other
projects we interviewed a single identified team leader.
In order to address our goal of unpacking differences
identified in phase 1 about development practices of
teams that involved members of vulnerable populations
compared to those that did not, our analyses identified 5
themes that were specific to developers who involved
members of vulnerable populations. We also identified
4 themes that were shared across all the interviews,
meaning that some aspects of involving vulnerable
populations were not different from involving mem-
bers of other types of populations. Finally, we identi-
fied barriers and facilitators to involving members of
vulnerable populations in the development of patient
decision aids.
Themes specific to involving members of vulnerable
populations
We identified three themes that explained the greater
likelihood of informal needs assessments in projects in
which members of vulnerable populations were specific-
ally involved. The informal activities served to center the
decision aid around users’ needs, to better avoid stigma,
and to ensure that the topic truly matters to the com-
munity. Two themes provided more insight into the
greater likelihood of recruiting participants through
community-based organizations. First, developers
reported that it is critical to build relationships of trust
with the community, a process that may be facilitated by
the structure of an established community group. In
addition, community-based organizations offer an im-
portant function by providing a nonthreatening and
often more feasible location for project activities.
Centering the decision aid around users’ needs
One theme that emerged from developers who involved
members of vulnerable populations is the importance of
adapting the design to better address users’ needs and
perspectives. They noted that this may be easier to do
earlier in the development process and requires not
being too fixated on the original plan.
“I think it would be really to keep an open mind and
not go into a project thinking that you know exactly
how it’s going to go and what the end result is going
to be. Because, when you do that, you start to put
aside what you’re [seeking] from your target audience.
[…] And to be as open minded as you can. What it’s
going to look like at the end is really a key component
to making sure that it ends up the way that your
audience really wants it to be.” (Project 4)
Avoiding stigmatizing representation
Developers indicated that they paid attention to how to
best represent members of vulnerable populations not
only in the final product, but also in every step of their
process. From the recruitment process to team inter-
action during development activities, developers who
involved members of vulnerable populations worked
with communities to ensure representations that avoided
discrimination and stigma. They focused on labels, how
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to represent people, what wording to use and how to
avoid potentially stigmatizing imagery or text, including
in logos and video:
“… how to film people, how to present people, even
down to the choice of who is going to be the narrator.
And the importance of gender, and race, ethnicity…”
(Project 1)
Choosing a topic that matters to the users’ community
For projects that specifically involved members of vul-
nerable populations, developers told us that they per-
ceived users’ involvement as being motivated by their
commitment to a topic that affected them and their
community. Developers saw the people involved in the
projects as wanting to make a positive difference for
their community and that, by participating in the pro-
ject, people were contributing to the community to
which they belonged.
“I certainly can’t talk for them but I think that they
felt it was important, they felt that it was something
they were doing for their own community. And they
could come share their experience in a way that
would be helpful to their community. So yeah, I think
that they felt that it was an important thing for them
to do.” (Project 4)
“I think the topic helped, because it was something
that there seemed to be a genuine interest in.”
(Project 6)
Taking the time to build relationships of trust
When involving members of vulnerable populations,
developers told us that it is important to take time to
build trust-based relationships of mutual respect. Partici-
pants pointed to the importance of building trust-based
relationships early in the project and often before the
development of the tool itself. These relationships help
ensure that people feel comfortable participating in pro-
ject activities and that their participation is maintained
throughout the process. Developers reported that it took
time to build these relationships.
“I think there was one focus group that we had
scheduled that I think maybe only two people showed
up and so… We had to kind of reschedule that and…
So that took a lot of time and patience on the part of
our research staff to really try to build a relationship
with some of these patients so that they were
trustful.” (Project 4)
“It’s not something that you can just show up at the
[…] event … contacting them a week in advance and
walking in and conduct a focus group… It takes a
long time to develop those relationships and to build
the trust that is needed in order to do these kinds of
studies.” (Project 5)
Meeting people in their environment
Developers who specifically involved members of vulner-
able populations emphasized the importance of a devel-
opment process that is not medicalized. For this reason,
their recruitment processes and project activities typic-
ally took place in community-based settings. Having
researchers go to the community, rather than vice versa,
facilitates both the recruitment process and ongoing user
participation throughout the project. It may also help
members of the community feel more comfortable and
less stigmatized. On a more practical level, such logis-
tical choices mean that people may also be less likely to
face barriers to participation such as transportation time
and costs.
“I think if you’re dealing with a clinically hard-to-
reach population who don’t have access to additional
services, then a community setting can offer that way
in to people that are otherwise difficult to reach.
[…] I think what certainly did help was to use a
community-based setting in our research because it
was a friendly environment, it was a place where
people were comfortable and happy going in where
they felt supported and it was somewhere that didn’t
feel particularly medicalized. So it was, it had kind of
a casual environment to it, it was somewhere where
people felt happy dropping in and staying for, you
know, a cup of tea and a chat. So it did kind of put
that sort of feeling around rather than feeling like you
were being assessed clinically.” (Project 6)
Themes shared across all the interviews
The importance of involving users in the process of
developing a patient decision aid
A majority of developers emphasized that they felt it was
important to involve patients in the development
process because they are the ultimate users of the deci-
sion aid. Patients bring their own perspectives to the
table that developers may not otherwise have, and can
help ensure the tool ultimately reflects what matters to
its users.
“We really do believe in stakeholder engagement.
[…] It really enhances the work that we do.
[…] I think what often happens is we don’t engage
them. We know what the answer is, and we put
something together and then we will engage them
after the final steps, right? But, here, we’re engaging
them at every step, to make sure that we’re on the
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right track. They’re really guiding us, you know?”
(Project 1)
“But, we don’t generally involve the patients: what
they want to know, how they understand things. So,
I’d say that you need to start involving the end user in
the process, you need to start thinking about that,
because a lot of people don’t even do that.” (Project 8)
Patients’ feedback can lead to many changes to the content
and the format of the tool
Developers told us that patients had significant impact
on the decision aid. Major modifications were made to
decision aids based on their feedback. Some developers
even noted that they revamped the entire tool based on
patients’ feedback. The majority of developers told us
that by incorporating patients’ feedback, they felt that
their decision aid changed for the better and that if they
had to do it again, they would do the same.
“And I am so glad that we did that, because […] I
think we started off with what we tend to do, which
is: OK, here’s something we developed. And almost,
you know, of course you don’t say it this way, but in a
way, what probably comes off: ‘Oh, here’s something
we developed, isn’t it beautiful? Approve it.’And I
love that we have a pretty strong and vocal
community advisory panel who said: Wait a second,
wait a second. This doesn’t even really… you know,
make sense.” (Project 2)
“It appeared that they saw things very differently
and they thought differently. So we actually
changed some important things based on their
views.” (Project 9)
Involving users is time– and resource-intensive, but is worth it
Developers indicated that the more patients and other
stakeholders were involved, the more useful input devel-
opers could get. They agreed that engaging more people
pays off in the end; however, they also noted that this
takes time. Some of them stated that they had underesti-
mated the time and budget required for their develop-
ment process and that they have learned to plan better
through experience.
“What I do differently is that, now that I’ve done
this a few times, I know how to write this better in
a grant application. And allow the amount of time
and resources that are needed to do it well.”
(Project 2)
“Gosh, I think probably the main lesson is that, from
my perspective, recruitment, it generally takes longer
than you anticipate that it’s going to take. […]
[However] I think it was very useful to involve people
in the two stages that we did.” (Project 8)
The challenge of incorporating opposing opinions
Seeking significant feedback from users may mean that
developers encounter conflicting opinions held by differ-
ent stakeholders. Developers found it challenging to rec-
oncile these different opinions. As one developer said,
“Some [patients] said we had too much, some said we
had not enough,” (Project 10) challenging the develop-
ment team to integrate all patients’ views.
Table 2 Barriers and facilitators to involving people who are
members of vulnerable populations
Barriers
1. Scheduling: People are busy, may be sick, and research teams have
to consider multiple and possibly conflicting schedules to be able to
gather everyone together.
2. Transportation: Transportation costs can be a barrier to members of
vulnerable populations.
3. Ethical procedures: Institutional review boards’ established
procedures may not be suited to some populations; for example,
detailed consent forms may present difficulties for people with lower
literacy, even when read aloud.
4. Lack of trust: People may refuse to participate due to a lack of trust
in the research team.
5. Finding an appropriate workload: It can be difficult to find the sweet
spot between enough involvement for meaningful participation but not
so much that it becomes overwhelming.
6. Project planning: Projects that involve members of vulnerable
populations may require more time, possibly a bigger budget and more
planning, which may or may not be feasible within the constraints of
funded research projects.
Facilitators
1. Flexibility in scheduling: Teams should work around scheduling
constraints, including people’s other commitments such as work and
caregiving activities.
2. Location: A community-based setting helps reduce potential power
imbalances and can also help with logistics.
3. Favourable institutional environment: It is helpful to work with an
institutional review board or research ethics committee who already
have knowledge or who are open to learning more about norms and
best practices in research involving members of vulnerable populations.
4. Relationship of trust: The research team needs to take the time to
build trust with patient partners from vulnerable populations and also
with all the other people involved in the project, including
community workers and health care professionals.
5. Enjoyable methods: Having activities that people enjoy can stimulate
sustainable participation in project; for example, people may enjoy focus
groups more than filling out questionnaires.
6. Adapting the technology: It may be necessary to adapt technology;
for example, particularly when working with people who are
members of populations with lower literacy and less access to
internet, communication by email may not be ideal.
7. Financial and material incentives: Remuneration, honoraria, or
material incentives provide a way to say thank you and to demonstrate
the value and importance of people’s participation in the project.
8. Relevance and importance of topic to the community: Ensuring
the topic is relevant and important to the community encourages
interest and commitment.
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Barriers and facilitators to involving members of
vulnerable populations
We explicitly asked developers who had specifically involved
members of vulnerable populations in the development
process of patient decision aids about the barriers and
facilitators of such involvement, summarized in Table 2.
We note that many facilitators were responses to barriers.
Discussion
This study aimed to describe and compare the develop-
ment practices of research teams that did and did not
specifically involve members of vulnerable populations
in the development of patient decision aids. Our study
had four principal findings.
First, in terms of how they involved users in the devel-
opment of a patient decision aid, there appeared to be
relatively few differences between teams that did and did
not specifically involve members of vulnerable popula-
tions. Even in an exploratory analysis of 31 potential var-
iables describing development practices and surrounding
issues, we found only 2 variables that differed signifi-
cantly. Similarly, interviews revealed common themes
about the importance of involving users, the value of in-
volving them early and throughout the development
process, and the need to allocate resources—both time
and funds—to such involvement.
Second, the few differences that we did observe had to
do with ensuring that the decision aid and its develop-
ment process were centered around users and their
communities. Such an approach may be either more
important or simply more common when involving
members of vulnerable populations. Results from our
secondary analysis of systematic review data suggested
that, when involving members of vulnerable populations,
decision aid development processes were more likely to
include an informal needs assessment, meaning any
activities that help the team identify what matters to the
people for whom the decision aid is designed. Such
activities explicitly help center the decision aid around
users’ needs. Our qualitative analyses unpacked this
finding and suggested that this work may consist primar-
ily of identifying what matters to the community and en-
suring that materials do not evoke or perpetuate stigma
and discrimination. In so doing, developers may encour-
age involvement that is rooted in people’s commitment
to addressing a topic that matters to their community.
In this sense, these activities may help enact or reinforce
community agency and power by explicitly providing
community members an opportunity to express what
matters to them and to their community.
Third, building trust was a theme that stood out in every
interview with developers who involved members of
vulnerable populations in their project and may be an-
other aspect of informal needs assessments. Trust-based
relationships played a role in the recruitment process and
in maintaining users’ participation throughout the entire
development process. Recruiting members of vulnerable
populations to a research project is facilitated when a rela-
tionship of trust is established before beginning the pro-
ject. Interviewees reported that this often meant that the
principal investigator or other team members already had
a link with a particular community. In some cases, team
members were also members of the population in ques-
tion, and thus served in a bridging role. Established rela-
tionships may help to ensure better representation of
community needs within a project and also help to avoid
what is sometimes called parachute research, meaning
when researchers come into a community, collect the data
they need, and never return.
Fourth, related to our third point, our quantitative
analyses also suggested that specifically involving mem-
bers of vulnerable populations is associated with collab-
orating with a community-based organization for
recruitment. Qualitative analyses further suggested that
teams not only recruit through community-based orga-
nizations, but also do the work there. When develop-
ment activities and other aspects of the research project
take place in community-based settings, it can reduce
logistical barriers and may also reduce power imbalances.
Limitations
Our findings present four main limitations. First, due to a
number of barriers, we were not able to interview patients
who had been involved in the development processes. We
believe developers provided credible and valuable insights
to understand differences in development practices when
involving vulnerable populations; however, to fully under-
stand the processes, it would have been preferable to
interview some of the people they involved as well. Sec-
ond, because our data came from a systematic review, we
were limited by what was reported in publications. All of
the data we used in this study were validated by the ori-
ginal authors; however, there may be important aspects of
the development process that we were unable to capture;
for example, the friendliness and openness of the team
members. Third, for phase 2 of our study, we focused on
specific categories of potential vulnerability: people who
may be marginalized, face discrimination or face stigma
due to lower education, income or literacy, race, ethnicity,
or mental health conditions. We made this choice for rea-
son of scope, and these categories of vulnerability were
more highly represented in our sample. However, it is pos-
sible that this choice may mean that our results do not
apply to other reasons for which a population might be
vulnerable. Fourth, the question of how to best involve the
people who may ultimately benefit from research—pati-
ents and other stakeholders—is not exclusive to patient
decision aid research. Our work focused on patient
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decision aid development because it provided a rich litera-
ture of descriptions of development processes and because
questions of how best to involve users are of primary
interest when they will be directly using the products of
the project. However, this choice of focus may mean that
our findings may not be applicable outside the sphere of
patient decision support and shared decision-making
research.
Comparison with prior work
Bonevski and colleagues [8] found several barriers and
facilitators to the involvement of members of socioeco-
nomically disadvantaged groups in medical and health
research. Their review addressed research in general,
which includes not only development of patient-oriented
tools like decision aids but also randomized controlled
trials, observational cohort studies, and other research
methods. Their analysis examined barriers at five stages
of a typical study: sampling, recruitment, data collection,
intervention delivery and retention throughout the
study, if applicable, and they reported a wide array of
barriers across these five stages, including lack of trust,
fear of being publicly exposed and concern that the re-
search may cause harm or stigma. As with our findings,
partnering with community groups was a commonly-used
approach in the included studies to address such barriers,
and the authors also synthesized a number of other facili-
tators including avoiding “fly in, fly out” research that fails
to give back to the community, adapting study materials
in terms of literacy levels or technology use, and various
approaches to ensuring cultural competence.
Our findings can also be placed in the context of a long
history of participatory action research in health. Partici-
patory action research emphasizes the importance of in-
volving communities in the research process, aims to
avoid power imbalances and build trust, and prioritizes
working with a community to effect change [21, 22].
These three principles can be seen in our findings. All de-
velopers we interviewed emphasized the importance of
working with research end users, but those who involved
members of vulnerable populations spoke specifically
about involving communities. The second principle is
reflected in themes we identified around researchers going
to the community, paying close attention to issues of
stigma and building relationships of trust. However, our
comparison with this principle is challenged by the fact
that we were unable to interview any of the patients who
had been involved in these projects. This may be a func-
tion of the overall research enterprise and the way ethical
oversight works within it, as well as our decision to
approach teams by way of published articles. Had we
sought out projects by directly contacting community-
based organizations, we might have had different results.
The third principle of participatory action research,
effecting change, is less well reflected in our findings.
However, in the case of patient decision aids, if the deci-
sion support is needed within a community, developing a
patient decision aid is one way to help bring about that
change.
Our work is also situated in the context of a rapidly
evolving literature on patient, public and service user in-
volvement in research projects of various kinds. Many
contributions to this literature have highlighted similar
issues to those identified in our study, including more
time and funding required [23, 24] and the importance
of working in partnership with communities [25, 26]
including going to the community and conducting activ-
ities in the community’s environment [27].
Conclusions
Developers of patient decision aids who do or do not
specifically involve members of vulnerable populations
have similar development practices overall, with a few
key differences. Those who involve members of vulner-
able populations may be more likely put more focus on
centering the decision aids around its eventual users by
conducting activities to assess their needs and by pilot-
testing the decision aid with potential users. They are
also more likely to recruit participants through
community-based organizations. These practices require
partnering with communities before and throughout a
project to build and maintain relationships of trust.
These approaches are likely to have benefits for working
with any population or community, but may be particu-
larly important when working with members of vulnerable
populations, who stand to benefit the most from these
tools. It is important to ensure that patient decision aids
are usable by all so that these tools can be better used in
real-world settings. However, identified facilitators for
involving members of vulnerable populations may require
time and resources that go beyond a typical funded
research project. Funders could help address this by expli-
citly allowing longer lead-up times to funding application
deadlines or by enabling the early stages of projects to
focus on needs assessment and relationship-building be-
tween researchers and communities. Decision aid deve-
lopers in our study often had existing relationships with
communities that they had built over time. Although it
may be difficult to assess, funders may wish to consider
funding criteria that includes the strength and sustain-
ability of such existing relationships. Researchers, com-
munities and funders could work together to ensure
that the needs and perspectives of members of vulnerable
populations are incorporated into project planning. Fi-
nally, funders may wish to initiate, continue or increase
support for community-initiated or community-driven
research.
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